Interdicting protease-activated receptor-2-driven inflammation with cell-penetrating pepducins

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 20, 2011, Pages 8491-8496

  Sevigny, Leila M ^a   Zhang, Ping ^a   Bohm, Andrew ^a   Lazarides, Katherine ^a   Perides, George ^a   Covic, Lidija ^a   Kuliopulos, Athan ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Protease activated receptor 1; Protease activated receptor 4

Indexed keywords

CARRAGEENAN; G PROTEIN COUPLED RECEPTOR; INTERLEUKIN 8; KAOLIN; LIPOPEPTIDE; PEPDUCIN; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 4; TRYPTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CANCER CELL; COLON CANCER; CONTROLLED STUDY; DRUG DESIGN; DRUG TARGETING; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INFLAMMATION; MAST CELL; MOUSE; NEUTROPHIL; NONHUMAN; PATHOPHYSIOLOGY; PAW EDEMA; PHARMACOPHORE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; COLONIC NEOPLASMS; INFLAMMATION; LIPOPEPTIDES; MAST CELLS; MICE; NEUTROPHILS; RECEPTOR, PAR-2; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; TRYPSIN; TRYPTASES;

MUS;

EID: 79957744641     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1017091108     Document Type: Article

References (39)

1. Vergnolle N, Hollenberg MD, Sharkey KA, Wallace JL (1999) Characterization of the inflammatory response to proteinase-activated receptor-2 (PAR2)-activating peptides in the rat paw. Br J Pharmacol 127:1083-1090. (Pubitemid 29326629)
2. Schmidlin F, et al. (2002) Protease-activated receptor 2 mediates eosinophil infiltration and hyperreactivity in allergic inflammation of the airway. J Immunol 169:5315-5321. (Pubitemid 35217205)
3. Vergnolle N, et al. (2001) Proteinase-activated receptor-2 and hyperalgesia: A novel pain pathway. Nat Med 7:821-826. (Pubitemid 32691637)
4. Kelso EB, et al. (2006) Therapeutic promise of proteinase-activated receptor-2 antagonism in joint inflammation. J Pharmacol Exp Ther 316:1017-1024. (Pubitemid 43345273)
5. Shi X, Gangadharan B, Brass LF, Ruf W, Mueller BM (2004) Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis. Mol Cancer Res 2: 395-402. (Pubitemid 39031073)
6. Kaneider NC, Agarwal A, Leger AJ, Kuliopulos A (2005) Reversing systemic inflammatory response syndrome with chemokine receptor pepducins. Nat Med 11:661-665. (Pubitemid 40868307)
7. Nystedt S, Emilsson K, Wahlestedt C, Sundelin J (1994) Molecular cloning of a potential proteinase activated receptor. Proc Natl Acad Sci USA 91:9208-9212. (Pubitemid 24297883)
8. Boire A, et al. (2005) PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell 120:303-313. (Pubitemid 40222426)
9. Trivedi V, et al. (2009) Platelet matrix metalloprotease-1 mediates thrombogenesis by activating PAR1 at a cryptic ligand site. Cell 137:332-343.
10. Ossovskaya VS, Bunnett NW (2004) Protease-activated receptors: Contribution to physiology and disease. Physiol Rev 84:579-621. (Pubitemid 38365493)
11. Noorbakhsh F, et al. (2006) Proteinase- activatedreceptor2modulatesneuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis. J Exp Med 203: 425-435.
12. Cenac N, et al. (2002) Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2. Am J Pathol 161:1903-1915. (Pubitemid 35265547)
13. Antoniak S, et al. (2010) Protease-activated receptor 2 deficiency reduces cardiac ischemia/reperfusion injury. Arterioscler Thromb Vasc Biol 30:2136-2142.
14. Lam DK, Schmidt BL (2010) Serine proteases and protease-activated receptor 2- dependent allodynia: A novel cancer pain pathway. Pain 149:263-272.
15. Ferrell WR, et al. (2003) Essential role for proteinase-activated receptor-2 in arthritis. J Clin Invest 111:35-41. (Pubitemid 36134846)
16. Ferrell WR, Kelso EB, Lockhart JC, Plevin R, McInnes IB (2010) Protease-activated receptor 2: A novel pathogenic pathway in a murine model of osteoarthritis. Ann Rheum Dis 69:2051-2054.
17. Molino M, et al. (1997) Interactions of mast cell tryptase with thrombin receptors and PAR-2. J Biol Chem 272:4043-4049. (Pubitemid 27078466)
18. Caughey GH (2007) Mast cell tryptases and chymases in inflammation and host defense. Immunol Rev 217:141-154.
19. Goh FG, Ng PY, Nilsson M, Kanke T, Plevin R (2009) Dual effect of the novel peptide antagonist K-14585 on proteinase-activated receptor-2-mediated signalling. Br J Pharmacol 158:1695-1704.
20. Covic L, Gresser AL, Talavera J, Swift S, Kuliopulos A (2002) Activation and inhibition of G protein-coupled receptors by cell-penetrating membrane-tethered peptides. Proc Natl Acad Sci USA 99:643-648. (Pubitemid 34106565)
21. Kaneider NC, et al. (2007) 'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage. Nat Immunol 8:1303-1312.
22. Covic L, Tchernychev B, Jacques S, Kuliopulos A (2007) Handbook of Cell-Penetrating Peptides, ed Langel U (Taylor and Francis, Boca Raton), pp 245-257.
23. Wielders SJ, Bennaghmouch A, Reutelingsperger CP, Bevers EM, Lindhout T (2007) Anticoagulant and antithrombotic properties of intracellular protease-activated receptor antagonists. J Thromb Haemost 5:571-576. (Pubitemid 46680691)
24. Tressel SL, et al. (2011) Pharmacology, biodistribution, and efficacy of GPCR-based pepducins in disease models. Methods Mol Biol 683:259-275.
25. Leger AJ, et al. (2006) Blocking the protease-activated receptor 1-4 heterodimer in platelet-mediated thrombosis. Circulation 113:1244-1254.
26. Teller DC, Okada T, Behnke CA, Palczewski K, Stenkamp RE (2001) Advances in determination of a high-resolution three-dimensional structure of rhodopsin, a model of G-protein-coupled receptors (GPCRs). Biochemistry 40:7761-7772. (Pubitemid 32622966)
27. Kjelsberg MA, Cotecchia S, Ostrowski J, Caron MG, Lefkowitz RJ (1992) Constitutive activation of the alpha 1B-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation. J Biol Chem 267: 1430-1433.
28. DeFea KA, et al. (2000) beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2. J Cell Biol 148: 1267-1281.
29. Roosterman D, Schmidlin F, Bunnett NW (2003) Rab5a and rab11a mediate agonist-induced trafficking of protease-activated receptor 2. Am J Physiol Cell Physiol 284: C1319-C1329. (Pubitemid 36457413)
30. Stalheim L, et al. (2005) Multiple independent functions of arrestins in the regulation of protease-activated receptor-2 signaling and trafficking. Mol Pharmacol 67:78-87. (Pubitemid 40069968)
31. Damiano BP, et al. (1999) Cardiovascular responses mediated by protease-activated receptor-2 (PAR-2) and thrombin receptor (PAR-1) are distinguished in mice deficient in PAR-2 or PAR-1. J Pharmacol Exp Ther 288:671-678. (Pubitemid 29119680)
32. Day SM, Lockhart JC, Ferrell WR, McLean JS (2004) Divergent roles of nitrergic and prostanoid pathways in chronic joint inflammation. Ann Rheum Dis 63:1564-1570. (Pubitemid 39573682)
33. Palmer HS, et al. (2007) Protease-activated receptor 2 mediates the proinflammatory effects of synovial mast cells. Arthritis Rheum 56:3532-3540. (Pubitemid 350100686)
34. Carvalho M, Benjamim C, Santos F, Ferreira S, Cunha F (2005) Effect of mast cells depletion on the failure of neutrophil migration during sepsis. Eur J Pharmacol 525: 161-169. (Pubitemid 41689038)
35. Takeuchi T, et al. (2000) Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates. J Biol Chem 275:26333-26342.
36. Cocks TM, et al. (1999) A protective role for protease-activated receptors in the airways. Nature 398:156-160.
37. Moraes TJ, et al. (2008) Role of PAR2 in murine pulmonary pseudomonal infection. Am J Physiol Lung Cell Mol Physiol 294:L368-L377. (Pubitemid 351253374)
38. Kanke T, et al. (2009) Novel antagonists for proteinase-activated receptor 2: Inhibition of cellular and vascular responses in vitro and in vivo. Br J Pharmacol 158:361-371.
39. Swift S, et al. (2010) A novel protease-activated receptor-1 interactor, Bicaudal D1, regulates G protein signaling and internalization. J Biol Chem 285:11402-11410.